Patent examiners operate under a complex network of production and quality incentives that influence the likelihood that an examiner will
Continue Reading Patent Strategy Should Consider Examiner Incentives
IP Assignment Considerations for Emerging Companies
Founders of emerging companies must decide early on in their company’s growth cycle whether to require employees to assign their
Continue Reading IP Assignment Considerations for Emerging Companies
Considerations for Protecting your Invention with Provisional Patent Applications
Since the U.S. patent law switched to the first-inventor-to-file system in 2013, provisional applications have become more popular as the
Continue Reading Considerations for Protecting your Invention with Provisional Patent Applications
Dana-Farber Launches New Fund to Support Oncology Startups
2021 started off well for Dana-Farber Cancer Institute, with the launch of its new venture fund, Binney Street Capital,
Continue Reading Dana-Farber Launches New Fund to Support Oncology Startups
Microsoft Partners with Broad Institute and Verily to Expand Terra Platform for Biomedical Research
On January 11, 2020, the Broad Institute, Verily Life Sciences, and Microsoft announced a strategic partnership to accelerate biomedical innovations
Continue Reading Microsoft Partners with Broad Institute and Verily to Expand Terra Platform for Biomedical Research
Practice Tips: Fair Use of a Trademark (Part II)
Sometimes it is necessary to use a third-party trademark to refer to the owner of a trademark or its goods
Continue Reading Practice Tips: Fair Use of a Trademark (Part II)
USPTO Incentive Policies Influence Patentability Decisions
U.S. Patent and Trademark Office human resource policies influence patentability decisions, potentially increasing the rate at which examiners issue allowances.
Continue Reading USPTO Incentive Policies Influence Patentability Decisions
Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
Earlier this week, Biogen and ViGeneron signed a global collaboration and licensing agreement to develop gene therapies for inherited eye
Continue Reading Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquire emerging Swiss biotech company
Continue Reading The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
How to Reduce Fees and Speed Time to Allowance at the US Patent & Trademark Office
It is advantageous for emerging companies to highlight their patent portfolio when seeking to attract investment, forge strategic partnerships, enter
Continue Reading How to Reduce Fees and Speed Time to Allowance at the US Patent & Trademark Office